Form 4: Kirsten Marie Kliphouse, Labcorp Holdings Inc. Director, Reports Acquisition of Restricted Stock Units

Director Kirsten Marie Kliphouse reports acquisition of 897 restricted stock units in Labcorp Holdings Inc.

Summary

• Kirsten Marie Kliphouse, a director of Labcorp Holdings Inc. (LH), filed a Form 4 on February 13, 2025, reporting a transaction.
• On February 11, 2025, Kliphouse acquired 897 Restricted Stock Units (RSUs) which convert to common stock.
• These RSUs vest fully on February 11, 2026.
• Following the transaction, Kliphouse directly owns 897 derivative securities.
• On May 17, 2024, Laboratory Corporation of America Holdings ('LCAH') reorganized into a new holding company structure, with LHI becoming the parent holding company.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing a director's acquisition of restricted stock units. While the acquisition itself could be seen as a positive sign of confidence, the filing is primarily informational.

Positives

• The acquisition of RSUs by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the RSUs on February 11, 2026, represents a future event where the director will receive shares of Labcorp Holdings Inc. common stock.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company director.

Key Dates

Keywords

Form 4, Labcorp Holdings Inc., Director, Kliphouse, Restricted Stock Units, LHI, LCAH, Beneficial Ownership